152 related articles for article (PubMed ID: 10377758)
1. Genetics of skin tumor promotion.
Angel JM; DiGiovanni J
Prog Exp Tumor Res; 1999; 35():143-57. PubMed ID: 10377758
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
Angel JM; Caballero M; DiGiovanni J
Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
[TBL] [Abstract][Full Text] [Related]
3. Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humans.
Abel EL; Angel JM; Riggs PK; Langfield L; Lo HH; Person MD; Awasthi YC; Wang LE; Strom SS; Wei Q; DiGiovanni J
J Natl Cancer Inst; 2010 Nov; 102(21):1663-75. PubMed ID: 20966433
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of the mapping of a 12-O-tetradecanoylphorbol-13-acetate promotion susceptibility locus, Psl1, to distal mouse chromosome 9.
Angel JM; Caballero M; DiGiovanni J
Mol Carcinog; 2001 Dec; 32(4):169-75. PubMed ID: 11746828
[TBL] [Abstract][Full Text] [Related]
5. Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Angel JM; Beltrán L; Minda K; Rupp T; DiGiovanni J
Mol Carcinog; 1997 Oct; 20(2):162-7. PubMed ID: 9364205
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor development.
Angel JM; Abel EL; Riggs PK; McClellan SA; DiGiovanni J
G3 (Bethesda); 2014 Apr; 4(6):1071-9. PubMed ID: 24700353
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
Naito M; Chenicek KJ; Naito Y; DiGiovanni J
Carcinogenesis; 1988 Apr; 9(4):639-45. PubMed ID: 3128409
[TBL] [Abstract][Full Text] [Related]
8. Genetic factors controlling responsiveness to skin tumor promotion in mice.
DiGiovanni J
Prog Clin Biol Res; 1995; 391():195-212. PubMed ID: 8532717
[TBL] [Abstract][Full Text] [Related]
9. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice.
DiGiovanni J; Imamoto A; Naito M; Walker SE; Beltrán L; Chenicek KJ; Skow L
Carcinogenesis; 1992 Apr; 13(4):525-31. PubMed ID: 1576703
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion.
Riggs PK; Angel JM; Abel EL; DiGiovanni J
Mol Carcinog; 2005 Oct; 44(2):122-36. PubMed ID: 16044405
[TBL] [Abstract][Full Text] [Related]
11. Genetic background and development of skin tumors.
Naito M; DiGiovanni J
Carcinog Compr Surv; 1989; 11():187-212. PubMed ID: 2493334
[TBL] [Abstract][Full Text] [Related]
12. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
[TBL] [Abstract][Full Text] [Related]
13. Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
Shen J; Abel EL; Riggs PK; Repass J; Hensley SC; Schroeder LJ; Temple A; Chau A; McClellan SA; Rho O; Kiguchi K; Ward MD; Semmes OJ; Person MD; Angel JM; Digiovanni J
Carcinogenesis; 2012 Nov; 33(11):2208-19. PubMed ID: 22782996
[TBL] [Abstract][Full Text] [Related]
14. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
Stern MC; Benavides F; LaCava M; Conti CJ
Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
[TBL] [Abstract][Full Text] [Related]
15. A wild-derived inbred mouse strain, MSM/Ms, provides insights into novel skin tumor susceptibility genes.
Okumura K; Saito M; Wakabayashi Y
Exp Anim; 2021 Aug; 70(3):272-283. PubMed ID: 33776021
[TBL] [Abstract][Full Text] [Related]
16. Multistage carcinogenesis in mouse skin.
DiGiovanni J
Pharmacol Ther; 1992; 54(1):63-128. PubMed ID: 1528955
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of polyamine-dependent susceptibility to skin tumorigenesis.
Megosh LC; Hu J; George K; O'Brien TG
Genomics; 2002 Apr; 79(4):505-12. PubMed ID: 11944982
[TBL] [Abstract][Full Text] [Related]
18. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion.
Reiners JJ; Nesnow S; Slaga TJ
Carcinogenesis; 1984 Mar; 5(3):301-7. PubMed ID: 6323045
[TBL] [Abstract][Full Text] [Related]
19. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.
Feith DJ; Shantz LM; Shoop PL; Keefer KA; Prakashagowda C; Pegg AE
Mol Carcinog; 2007 Jun; 46(6):453-65. PubMed ID: 17219416
[TBL] [Abstract][Full Text] [Related]
20. Genetics of chemical carcinogenesis--III. Tissue-specificity of the genes controlling susceptibility and resistance to skin carcinogenesis in the mouse.
Saran A; Bouthillier Y; Pioli C; Mouton D; Covelli V; Doria G; Neveu T; Biozzi G
Carcinogenesis; 1996 Nov; 17(11):2463-8. PubMed ID: 8968064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
